button_about us.jpg (12921 bytes)button_research.jpg (13036 bytes)button_education.jpg (13628 bytes)button_newsevents.jpg (15751 bytes)button_links.jpg (10752 bytes)


Welcome to the website of the Angiogenesis Laboratory Amsterdam

Angiogenesis is a key process in cancer. It is therefore a target in the development of novel anti-cancer therapies. The Angiogenesis Laboratory Amsterdam seeks to unravel the fundamental processes and mechanisms underlying angiogenesis and vascular development. The major aim is to use new knowledge and technology for the development of new treatment modalities in the .


New issue of Angiogenesis  
Special issue on novel signaling pathways in angiogenesis

 

Guest editors:

Roy Bicknell &

Judy R. van Beijnum

 

 

In memoriam dr. Judah Folkman

Tribute paper dr. Folkman by Domenico Ribatti

Topics:

Slits and roundabouts in cancer

Notch signaling in endothelium

Netrins and UNC5 in angiogenesis Neuropilin regulation of angiogenesis

Sprouty proteins as masterminds

TLR, RAGE and HMGB1 signaling

Wnt/frizzled signaling

Hedgehogs in development

NF-κB, a new player in angiostasis

Endoglin in vascular diseases


News item from the Angiogenesis Laboratory

'From jellyfish to mouse to man; luminous mice aid cancer research' In: Mare, weekly journal of the Leiden University.

Leiden University researchers have developed a nude mouse with fluorescent blood vessels. This mouse is developed as a tool for cancer research. Together with researchers from the Angiogenesis Laboratory in Maastricht this mouse was described and shown to be useful for the study of human cancer.

A transgenic Tie2-GFP athymic mouse model; a tool for vascular biology in xenograft tumors. Hillen et al. Biochem Biophys Res Commun. 368:364-7, 2008.


Recent research Other recent findings

Isolation of tumor endothelial cells

Van Beijnum et al. Nature protocols, 2008

 

Development of small-molecule topomimetics of anginex.

Dings et al. J.Natl.Cancer Inst., 2006.

 

The galectin profile of the endothelium.

Thijssen et al. Am. J. Pathol., 2008.

 

Epigenetic regulation of angiogenesis

Hellebrekers et al. Cancer Res., 2007.

 

Insight in the working mechanism of the in-house developed angiogenesis inhibitor Anginex.

Thijssen et al. PNAS, 2006.

 

 

Interleukin-21, a novel angiogenesis inhibitor.

Castermans et al. Blood, 2008

 

Making tumors vulnerable to the immune system by angiostasis.

Griffioen, Cancer Immunol. Immunother., 2008.

A quantum dot-based probe for molecular imaging of angiogenesis.

Mulder et al. Nano Letters, 2006.

Imaging of angiogenesis

Mulder et al. FASEB J., 2007

 

NF-kappaB in angiogenesis inhibition

Tabruyn & Griffioen, Cell Death Diff., 2007

 

No lymph angiogenesis in primary breast carcinoma.

Van der Schaft et al. Cancer Lett., 2007.

 

Anginex-labeled liposomes for targeting of tumor endothelium

Brandwijk et al. Bioconj Chem., 2007

 

Novel targets on tumor endothelial cells.

Van Beijnum et al. Blood, 2006.

 

Anti-angiogenesis enhances leukocyte infiltration in tumors.

Dirkx et al. FASEB J., 2006.

 

A new entry in angiostatic therapy

Griffioen, Blood, 2008.


NEWS & EVENTS

The Angiogenesis Laboratory Amsterdam in the news (articles only in Dutch)


Tracer, April 2009

 

 

 

 

Medische Oncologie March, 2007 

 

 

 

 

De Volkskrant, September 9th, 2006

 

 

More news

 

 

 

 

 

 

 

 

 

 

You are visitor

Hit Counter

mailb.gif (4007 bytes)

 

Last updated on

 

April 26th, 2009

 

Mare, Leids Universitair weekblad, March, 2008

 

 

 

C2W Life Scieces, Chemisch Tijdschrift, March, 2007

 

 

Summum, December 20th, 2006

© Bekkerlot 2006